Pfizer’s Post-Lipitor World


Published On: February 1st, 2012

With it exclusive window on cholesterol drug Lipitor long closed, Pfizer is looking to the post-Lipitor world. WSJ’s Spencer Jakab visits Mean Street to make the case that the company’s future is bright. Photo: Getty Images.

Read more:
Pfizer’s Post-Lipitor World/a>



Loading...


Comments are closed.